{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:45:55Z","timestamp":1794541555364,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,15]],"date-time":"2015-02-15T00:00:00Z","timestamp":1423958400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.vaccine.2014.10.081","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T14:33:52Z","timestamp":1415457232000},"page":"1107-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Considerations for developing an immunization strategy with enterovirus 71 vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.10.081_bib0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0010","series-title":"A guide to clinical management and public health response for hand, foot and mouth disease (HFMD)","author":"World Health Organization Western Pacific Region","year":"2011"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3201\/eid0809.010397","article-title":"Seroepidemiology of human enterovirus 71, Singapore","volume":"8","author":"Ooi","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0020","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1542\/peds.109.6.e88","article-title":"Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease\/herpangina in children during an epidemic in Taiwan","volume":"109","author":"Chang","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u20132012: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2009.02.002","article-title":"An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China","volume":"44","author":"Zhang","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00705-011-0929-8","article-title":"A large outbreak of hand, foot, and mouth disease caused by EV71 and CVA16 in Guangdong, China, 2009","volume":"156","author":"De","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0045","doi-asserted-by":"crossref","first-page":"e80515","DOI":"10.1371\/journal.pone.0080515","article-title":"Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0050","first-page":"69","article-title":"Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia","volume":"29","author":"Chua","year":"2007","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12250-011-3195-8","article-title":"Hand foot and mouth disease due to enterovirus 71 in Malaysia","volume":"26","author":"Chua","year":"2011","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0060","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3201\/eid1812.120929","article-title":"Enterovirus 71-associated hand, foot, and mouth disease, southern Vietnam, 2011","volume":"18","author":"Khanh","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0070","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","article-title":"The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains","volume":"14","author":"Wu","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1423-0127-21-16","article-title":"Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations","volume":"21","author":"Linsuwanon","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7883\/yoken.63.422","article-title":"Changing epidemiology of hand, foot, and mouth disease in Hong Kong, 2001\u20132009","volume":"63","author":"Ma","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0085","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1542\/peds.2006-3331","article-title":"Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998\u20132005","volume":"120","author":"Chen","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0090","doi-asserted-by":"crossref","first-page":"e83711","DOI":"10.1371\/journal.pone.0083711","article-title":"Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4161\/hv.19521","article-title":"Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial","volume":"8","author":"Meng","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0100","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1016\/j.ijid.2010.02.2265","article-title":"The enterovirus 71 epidemic in 2008\u2013public health implications for Hong Kong","volume":"14","author":"Ma","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0105","doi-asserted-by":"crossref","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","article-title":"Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/INF.0b013e3182116e95","article-title":"Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks","volume":"30","author":"Ma","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0115","first-page":"520","article-title":"Economic burden of hand, foot and mouth disease in Ningbo, Zhejiang","volume":"27","author":"Yang","year":"2012","journal-title":"Dis Surveill"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0120","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/INF.0b013e31826eba74","article-title":"Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants","volume":"31","author":"Zhu","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4161\/hv.28397","article-title":"Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0130","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0135","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/infdis\/jit429","article-title":"Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, randomized, doubleblind, placebo-controlled trial","volume":"209","author":"Li","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0145","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/CVI.00491-13","article-title":"Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months","volume":"20","author":"Hu","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0155","doi-asserted-by":"crossref","first-page":"e54451","DOI":"10.1371\/journal.pone.0054451","article-title":"Study of the integrated immune response induced by an inactivated EV71 vaccine","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0165","doi-asserted-by":"crossref","first-page":"e79788","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0170","doi-asserted-by":"crossref","first-page":"e79599","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy Chinese infants and children","volume":"8","author":"Mao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.10.081_bib0175","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1016\/j.vaccine.2010.09.065","article-title":"Forecasting the economic value of an enterovirus 71 (EV71) vaccine","volume":"28","author":"Lee BY1","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1401500X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1401500X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:26:17Z","timestamp":1689639977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1401500X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0264410X1401500X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for developing an immunization strategy with enterovirus 71 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}